Clinical Trial Update: Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset Seizures [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 dose-escalation study of cenobamate in pediatric patients with partial-onset seizures. The study status is comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures

Drugs mentioned

• Cenobamate (cenobamate)

Snippet

Sponsor: SK Life Science, Inc. | Conditions: Partial Epilepsy | Phase 1 | Status: COMPLETED